Roth Capital Comments on FIGS’s Q1 Earnings (NYSE:FIGS)

FIGS, Inc. (NYSE:FIGS) – Analysts at Roth Capital issued their Q1 2025 earnings estimates for shares of FIGS in a research report issued on Friday, February 28th. Roth Capital analyst M. Koranda anticipates that the company will post earnings per share of ($0.01) for the quarter. The consensus estimate for FIGS’s current full-year earnings is $0.01 per share. Roth Capital also issued estimates for FIGS’s Q3 2025 earnings at $0.00 EPS, Q4 2025 earnings at $0.03 EPS, FY2025 earnings at $0.04 EPS and FY2026 earnings at $0.15 EPS.

Several other research analysts also recently weighed in on FIGS. The Goldman Sachs Group reduced their price target on shares of FIGS from $5.00 to $4.50 and set a “sell” rating for the company in a research report on Tuesday, December 10th. Telsey Advisory Group reiterated a “market perform” rating and set a $7.00 price objective on shares of FIGS in a research note on Friday, February 28th. Finally, Barclays decreased their target price on FIGS from $5.00 to $4.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 12th. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $5.35.

FIGS Stock Performance

NYSE:FIGS opened at $4.82 on Monday. The stock has a market capitalization of $817.64 million, a PE ratio of 80.25, a P/E/G ratio of 31.62 and a beta of 1.22. FIGS has a fifty-two week low of $4.30 and a fifty-two week high of $7.06. The company has a fifty day moving average of $5.67 and a two-hundred day moving average of $5.77.

Insider Activity at FIGS

In other news, insider Heather L. Hasson sold 26,855 shares of the business’s stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $5.96, for a total transaction of $160,055.80. Following the transaction, the insider now directly owns 354,221 shares in the company, valued at $2,111,157.16. The trade was a 7.05 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 22.30% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On FIGS

A number of institutional investors have recently added to or reduced their stakes in FIGS. Sugar Maple Asset Management LLC acquired a new stake in shares of FIGS in the 4th quarter worth $43,000. Blue Trust Inc. grew its holdings in shares of FIGS by 380.0% in the fourth quarter. Blue Trust Inc. now owns 7,407 shares of the company’s stock valued at $51,000 after purchasing an additional 5,864 shares during the period. Stifel Financial Corp acquired a new stake in FIGS during the fourth quarter worth about $70,000. Cibc World Markets Corp purchased a new position in FIGS during the fourth quarter worth about $75,000. Finally, Creative Planning boosted its holdings in FIGS by 17.7% in the 3rd quarter. Creative Planning now owns 12,697 shares of the company’s stock valued at $87,000 after purchasing an additional 1,911 shares during the last quarter. Hedge funds and other institutional investors own 92.21% of the company’s stock.

About FIGS

FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.